Tekla Capital Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $25M | Sell |
82,403
-6,300
| -7% | -$1.75M | 0.98% | 29 |
|
|
2023
Q1 | $23.4M | Sell |
88,703
-16,300
| -16% | -$4.14M | 0.89% | 33 |
|
|
2022
Q4 | $25.2M | Sell |
105,003
-19,300
| -16% | -$4.32M | 0.95% | 32 |
|
|
2022
Q3 | $22.8M | Hold |
124,303
| – | – | 0.94% | 32 |
|
|
2022
Q2 | $20.9M | Hold |
124,303
| – | – | 0.82% | 32 |
|
|
2022
Q1 | $31.2M | Buy |
124,303
+12,342
| +11% | +$3.1M | 1.09% | 26 |
|
|
2021
Q4 | $28.8M | Hold |
111,961
| – | – | 0.93% | 33 |
|
|
2021
Q3 | $27.2M | Sell |
111,961
-12,782
| -10% | -$3.12M | 0.88% | 33 |
|
|
2021
Q2 | $25.8M | Sell |
124,743
-28,154
| -18% | -$5.74M | 0.84% | 29 |
|
|
2021
Q1 | $28.8M | Sell |
152,897
-22,200
| -13% | -$3.91M | 0.99% | 25 |
|
|
2020
Q4 | $28.8M | Buy |
175,097
+93,164
| +114% | +$13.6M | 1.01% | 25 |
|
|
2020
Q3 | $10.2M | Sell |
81,933
-1,900
| -2% | -$235K | 0.38% | 61 |
|
|
2020
Q2 | $8.14M | Hold |
83,833
| – | – | 0.31% | 66 |
|
|
2020
Q1 | $7.53M | Sell |
83,833
-12,000
| -13% | -$1.55M | 0.34% | 60 |
|
|
2019
Q4 | $14.2M | Sell |
95,833
-2,560
| -3% | -$344K | 0.54% | 40 |
|
|
2019
Q3 | $11.8M | Buy |
98,393
+8,824
| +10% | +$1.14M | 0.52% | 48 |
|
|
2019
Q2 | $12.1M | Hold |
89,569
| – | – | 0.49% | 49 |
|
|
2019
Q1 | $11.7M | Buy |
89,569
+15,234
| +20% | +$2.05M | 0.47% | 49 |
|
|
2018
Q4 | $9.25M | Hold |
74,335
| – | – | 0.4% | 52 |
|
|
2018
Q3 | $10.3M | Sell |
74,335
-755
| -1% | -$94K | 0.38% | 63 |
|
|
2018
Q2 | $7.7M | Sell |
75,090
-16,791
| -18% | -$1.7M | 0.29% | 77 |
|
|
2018
Q1 | $8.91M | Buy |
91,881
+28,449
| +45% | +$2.76M | 0.35% | 65 |
|
|
2017
Q4 | $5.57M | Sell |
63,432
-31,800
| -33% | -$2.55M | 0.21% | 84 |
|
|
2017
Q3 | $7.58M | Hold |
95,232
| – | – | 0.27% | 70 |
|
|
2017
Q2 | $8.3M | Buy |
95,232
+31,800
| +50% | +$2.69M | 0.31% | 63 |
|
|
2017
Q1 | $5.64M | Sell |
63,432
-126,800
| -67% | -$10.6M | 0.22% | 84 |
|
|
2016
Q4 | $14.1M | Buy |
190,232
+94,548
| +99% | +$7.08M | 0.6% | 37 |
|
|
2016
Q3 | $7.24M | Sell |
95,684
-239,314
| -71% | -$18.3M | 0.28% | 73 |
|
|
2016
Q2 | $25.8M | Hold |
334,998
| – | – | 1.05% | 26 |
|
|
2016
Q1 | $26.1M | Sell |
334,998
-113,490
| -25% | -$7.92M | 1.11% | 23 |
|
|
2015
Q4 | $30.3M | Buy |
448,488
+205,300
| +84% | +$14.3M | 1.1% | 21 |
|
|
2015
Q3 | $18.8M | Buy |
243,188
+29,400
| +14% | +$2.6M | 0.68% | 32 |
|
|
2015
Q2 | $19.4M | Buy |
213,788
+66,300
| +45% | +$5.31M | 0.7% | 31 |
|
|
2015
Q1 | $11.1M | Hold |
147,488
| – | – | 0.44% | 55 |
|
|
2014
Q4 | $10.8M | Buy |
147,488
+31,800
| +27% | +$2.24M | 0.51% | 47 |
|
|
2014
Q3 | $8.16M | Buy |
+115,688
| New | +$7.65M | 0.38% | 56 |
|
Other funds holding HCA
Tekla Capital Management's HCA Position: Q2 2023 in Review
Tekla Capital Management reduced its HCA Healthcare (HCA) stake by 7.1% in Q2 2023, selling an estimated $1.75M and leaving 82,403 shares worth $25M. The position accounts for 0.98% of the portfolio, ranked #29.
Tekla Capital Management first reported a position in HCA in Q3 2014 and has held it in 36 quarters since. The position peaked at $31.2M in Q1 2022. 1,014 funds tracked by Wall St. Rank hold HCA as of Q2 2023.
- Tekla Capital Management held 82,403 shares of HCA Healthcare worth $25M as of Q2 2023.
- Tekla Capital Management sold 6,300 HCA Healthcare shares in Q2 2023, an estimated $1.75M.
- HCA Healthcare made up 0.98% of Tekla Capital Management's portfolio in Q2 2023, its #29 holding.
- Tekla Capital Management first reported a position in HCA Healthcare in Q3 2014 and has held it in 36 quarters since.
- Tekla Capital Management's HCA Healthcare position peaked at $31.2M in Q1 2022.
- 1,014 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2023.
Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.